SCHEMBL679000

SCHEMBL679000

CNCC(=O)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2443603 0.97 VDR (0.34)
SCHEMBL28359845 0.88 TRPA1 (0.32)
SCHEMBL21850085 0.81 CA1 (0.34)
SCHEMBL22625757 0.80
SCHEMBL10774381 0.79 VDR (0.36)
SCHEMBL23253548 0.78
SCHEMBL13141640 0.78
Bromide SCHEMBL10780564 0.77 VDR (0.35)
SCHEMBL4547564 0.74 DPP4 (0.37)
SCHEMBL19295795 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230233526-A1 GRANZYME B INHIBITOR COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF SKIN BLISTERING AND/OR PEELING THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2023-07-27 US disclosed
CN-110831586-B Dimethyl-nonyltetraalkenyl-trimethyl-cyclohexyl compounds and uses thereof 密执安大学评议会 2023-06-13 CN disclosed
EP-4012814-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTIC-SOLUTION BATTERY Mitsubishi Chemical Corporation (JP) 2022-06-15 EP disclosed
US-11148998-B2 Dimethyl-nonatetraenyl-trimethyl-cyclohexyl compounds and uses thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2021-10-19 US disclosed
US-11149043-B2 Prodrug modulators of the integrated stress pathway CALICO LIFE SCIENCES LLC (US) 2021-10-19 US disclosed
CN-110831586-A Dimethyl-nonatetraenyl-trimethyl-cyclohexyl compound and application thereof 密执安大学评议会 2020-02-21 CN disclosed
US-10537652-B2 Cyclic urea compounds as granzyme B inhibitors VIDA THERAPEUTICS INC. (CA) 2020-01-21 US disclosed
US-20190151484-A2 CYCLIC UREA COMPOUNDS AS GRANZYME B INHIBITORS VIDA THERAPEUTICS INC. (CA) 2019-05-23 US disclosed
US-20180339961-A1 DIMETHYL-NONATETRAENYL-TRIMETHYL-CYCLOHEXYL COMPOUNDS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2018-11-29 US disclosed
US-9931347-B2 Pharmaceutical compound IOMET PHARMA LTD. (US) 2018-04-03 US disclosed
US-20110281862-A1 ALFA-CARBOLINE INHIBITORS OF NPM-ALK, RET, AND BCR-ABL UNIVERSITA' DEGLI STUDI DI MILANO - BICOCCA (IT) 2011-11-17 US disclosed
US-20110281862-A1 ALFA-CARBOLINE INHIBITORS OF NPM-ALK, RET, AND BCR-ABL UNIVERSITA' DEGLI STUDI DI MILANO - BICOCCA (IT) 2011-11-17 US disclosed
US-20110251379-A1 COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS SATORI PHARMACEUTICALS, INC. (US) 2011-10-13 US disclosed
US-7981903-B2 2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancer GLAXOSMITHKLINE LLC (US) 2011-07-19 US disclosed
US-7981903-B2 2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancer GLAXOSMITHKLINE LLC (US) 2011-07-19 US disclosed
US-20100204196-A1 2-[2--1H-Pyrrolo[2,3-D]Pyrimidin-4-YL)Amino] Benzamide Derivatives As IGF-1R Inhibitors For The Treatment Of Cancer GLAXOSMITHKLINE LLC 2010-08-12 US disclosed
US-20100204196-A1 2-[2--1H-Pyrrolo[2,3-D]Pyrimidin-4-YL)Amino] Benzamide Derivatives As IGF-1R Inhibitors For The Treatment Of Cancer GLAXOSMITHKLINE LLC 2010-08-12 US disclosed
US-20070244055-A1 Conjugates useful in the treatment of prostate cancer BRADY STEPHEN F 2007-10-18 US disclosed
US-20070129309-A1 Conjugates useful in the treatment of prostate cancer BRADY STEPHEN F 2007-06-07 US disclosed
US-20070021350-A1 Conjugates useful in the treatment of prostate cancer BRADY STEPHEN F 2007-01-25 US disclosed